Hydrocortisone acetate/Lidocaine Hydrochloride

醋酸氢化可的松/盐酸利多卡因

Report date: 2022/04/20 09:25:48

Base Information

Drug NameHydrocortisone acetate/Lidocaine Hydrochloride

Drug Alias Name醋酸氢化可的松-盐酸利多卡因Hydrocortisone acetate•Lidocaine hydrochlorideHydrocortisone acetate-Lidocaine hydrochloride醋酸氢化可的松+盐酸利多卡因乙酸氢化可的松/盐酸利多卡因 +[18]

ClassificationSmall molecules > Steroids

Mechanisms of ActionSodium channel alpha subunit blockersGlucocorticoid receptor agonists

TargetsSodium channel alpha subunitGlucocorticoid receptor

Therapy Area/IndicationsHemorrhoids

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Lidocaine Hydrochloride Hydrocortisone

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCitius Pharm

China Registration ClassN/A

Develop Information

Active CompaniesCitius Pharm

Inactive CompaniesN/A

Active IndicationsHemorrhoids

Inactive IndicationsN/A

Other Information

ATC CodeN/A